EUCLIDEAN CAPITAL LLC
Q3 2026 Form 13-F
NEW YORK, NEW YORK
CIK 0001825034
· Institutional investment manager
$323.6M Reported Value Total
Reported value
$323.6M
Quarter over quarter
-0.9%
Holdings
10
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Joseph Cosmai
Manager
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2026 13F record
Q3 2026 13F filing summary
| Period of report | September 30, 2026 |
|---|---|
| Filed | November 16, 2026 |
| Form | 13F-HR |
| Reported value | $323.6M |
| Positions | 10 |
| Change in reported value | -26.4% |
| New positions | 1 |
| Exited positions | 2 |
| Position turnover | 25.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
10 | $323.6M |
|
Q2 2026 13F
Filed Aug 14, 2026
|
11 | $439.8M |
|
Q1 2026 13F
Filed May 15, 2026
|
10 | $392.3M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
12 | $369.5M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
11 | $238.0M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
11 | $305.7M |
|
Q1 2025 13F
Filed May 15, 2025
|
11 | $266.1M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
11 | $736.7M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
12 | $906.8M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
11 | $795.8M |
|
Q1 2024 13F
Filed May 15, 2024
|
13 | $780.0M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
13 | $888.5M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
13 | $458.4M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
12 | $389.1M |
|
Q1 2023 13F
Filed May 15, 2023
|
10 | $114.0M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
11 | $106.9M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
10 | $107.7M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
10 | $117.6M |
|
Q1 2022 13F
Filed May 16, 2022
|
11 | $172.1M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
11 | $175.9M |
4 earlier quarters on file — choose one from the quarter menu above.
Top 10 holdings · Q3 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | VEU VANGUARD INTL EQUITY INDEX F | $269.1M | 83.15% |
| 2 | INDA ISHARES TR | $17.3M | 5.33% |
| 3 | ORIC ORIC PHARMACEUTICALS INC | $13.3M | 4.12% |
| 4 | TMS TEAMSHARES INC | $8.0M | 2.47% |
| 5 | FHTX FOGHORN THERAPEUTICS INC | $5.6M | 1.74% |
| 6 | PMVP PMV PHARMACEUTICALS INC | $4.4M | 1.36% |
| 7 | SRZN SURROZEN INC | $2.8M | 0.87% |
| 8 | ALEC ALECTOR INC | $2.4M | 0.75% |
| 9 | TNYA TENAYA THERAPEUTICS INC | $613.1K | 0.19% |
| 10 | MRLN MERLIN INC | $89.5K | 0.03% |
Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.